Is It Too Late To Consider Jazz Pharmaceuticals After Its Strong 2024 Share Price Rally? [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
Despite a soft patch recently, with the share price down 0.9% over the last week and 5.7% over the last month to about $166, Jazz is still up 34.1% year to date and 35.0% over the past year. This naturally raises questions about whether it is now fully priced. Recent moves have been shaped by ongoing investor focus on Jazz's narcolepsy and sleep disorder franchise, along with the market weighing its pipeline momentum and regulatory progress. At the same time, sentiment around specialty pharma has been shifting as investors reassess where they see sustainable growth and defensible cash flows. On our framework Jazz scores a 6/6 valuation check , suggesting it screens as undervalued across all of our standard tests. Next we will unpack those methods in detail before exploring a more powerful way to think about its true worth. Jazz Pharmaceuticals delivered 35.0% returns over the last year. See how this stacks up to the rest of the Pharmaceuticals industry. A Discounted Cash Flow
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals to Participate in Upcoming Investor Events [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- Jazz Pharmaceuticals to Participate in Upcoming Investor EventsPR Newswire
- 3 Value Stocks We're Skeptical Of [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
JAZZ
Earnings
- 11/5/25 - Beat
JAZZ
Sec Filings
- 12/11/25 - Form 4
- 12/10/25 - Form 3
- 12/9/25 - Form 144
- JAZZ's page on the SEC website